TY - JOUR
T1 - Membrane-permeant analogues of the putative second messenger myo-inositol 3,4,5,6-tetrakisphosphate
AU - Roemer, Stefan
AU - Stadler, Christoph
AU - Rudolf, Marco T.
AU - Jastorff, Bernd
AU - Schultz, Carsten
PY - 1996/7/21
Y1 - 1996/7/21
N2 - For future investigations of the binding properties of D-myo-inositol 3,4,5,6- and 1,4,5,6-tetrakis-phosphate [D-Ins(3,4,5,6)P4 and D-Ins(1,4,5,6)P4, respectively] to their putative target proteins, a set of analogues with modifications of the 1(3)- and/or 2-hydroxy group has been prepared. The reaction sequences started from D-3,4,5,6-tetra-O-benzyl-myo-inositol or its D-1,4,5,6-enantiomer, respectively and allowed the introduction of groups with degenerative hydrogen-bonding potential like methoxy or chloride, replacing the hydroxy groups. Additionally, the corresponding DL-scylto-inositol precursor 24 was prepared by a stereochemically optimized reduction of the 2-inosose derivative 23. Classical protection/deprotection chemistry and subsequent phosphorylation employing a common phosphite approach yielded the tetrakisphosphate analogues la-e, 3. These derivatives were converted to the uncharged, bioactivalable acetoxymethyl esters 2a-e, 4. To avoid cyclization of phosphates during acetoxymethyl alkylation and to increase lipophilicity of the potentially membrane-permeant InsP4 derivatives hydroxy groups of the monosubstituted tetrakisphosphates were covered by intracellularly hydrolysable butyrates.
AB - For future investigations of the binding properties of D-myo-inositol 3,4,5,6- and 1,4,5,6-tetrakis-phosphate [D-Ins(3,4,5,6)P4 and D-Ins(1,4,5,6)P4, respectively] to their putative target proteins, a set of analogues with modifications of the 1(3)- and/or 2-hydroxy group has been prepared. The reaction sequences started from D-3,4,5,6-tetra-O-benzyl-myo-inositol or its D-1,4,5,6-enantiomer, respectively and allowed the introduction of groups with degenerative hydrogen-bonding potential like methoxy or chloride, replacing the hydroxy groups. Additionally, the corresponding DL-scylto-inositol precursor 24 was prepared by a stereochemically optimized reduction of the 2-inosose derivative 23. Classical protection/deprotection chemistry and subsequent phosphorylation employing a common phosphite approach yielded the tetrakisphosphate analogues la-e, 3. These derivatives were converted to the uncharged, bioactivalable acetoxymethyl esters 2a-e, 4. To avoid cyclization of phosphates during acetoxymethyl alkylation and to increase lipophilicity of the potentially membrane-permeant InsP4 derivatives hydroxy groups of the monosubstituted tetrakisphosphates were covered by intracellularly hydrolysable butyrates.
UR - http://www.scopus.com/inward/record.url?scp=33748889514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748889514&partnerID=8YFLogxK
U2 - 10.1039/p19960001683
DO - 10.1039/p19960001683
M3 - Article
AN - SCOPUS:33748889514
SN - 0300-922X
SP - 1683
EP - 1694
JO - Journal of the Chemical Society - Perkin Transactions 1
JF - Journal of the Chemical Society - Perkin Transactions 1
IS - 14
ER -